113
Participants
Start Date
November 26, 2013
Primary Completion Date
October 27, 2016
Study Completion Date
October 27, 2016
Matching Placebo
twice daily dosing
Nintedanib
gelating capsule
Winthrop University Hospital, Mineola
Lowcountry Lung and Crit Care, Charleston
Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul
Clinical Research Center Sarasota Memorial Hosptial, Sarasota
Yedikule Gog. Hst. EAH, Istanbul
Sureyyapasa Gogus Hast. ve Gogus Cer. Egit. ve Aras. Has., Istanbul
Ege Universitesi T.F., Izmir
Dr.Suat Seren EAH, Izmir
Baptist Health Lexington, Lexington
ID Clinical Research, LTD, Toledo
Minnesota Lung Research, Minneapolis
Chest Medicine Clinical Services, Skokie
Annette C & Harold C Simmons Transplant Institute, Dallas
The Oregon Clinic, Portland
Western CT Medical Group, P.C., Danbury
Dartmouth-Hitchcock Medical Center, Lebanon
University of Alberta Hospital (University of Alberta), Edmonton
Vancouver General Hospital, Vancouver
St. Paul's Hospital, Vancouver
Concordia Hospital, Winnipeg
QEII Health Sciences Centre (Dalhousie University), Halifax
St. Joseph's Healthcare Hamilton, Hamilton
CHUS Fleurimont, Sherbrooke
Cukurova Universitesi Tip Fakultesi Gog. Hast. Anabilim Dali, Adana
Ankara Universitesi Tip Fakultesi, Ankara
Lead Sponsor
Boehringer Ingelheim
INDUSTRY